Liver Transplant CGM
Recruiting
Observational Study
Liver Transplant
Post Transplant Diabetes
Type 2 Diabetes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
• inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL
Exclusion Criteria:
* having a planned discharge to a rehabilitation or nursing facility,
* a contraindication to sensor placement,
* if discharge is anticipated to be \>30 days p…
Contacts